Explore the world of biopharmaceuticals: learn about the processes behind industry innovation and how they improve patients' lives every day.
Cancer is a heavy burden for patients as well as the economy. Find out how research is helping.
The 5-year survival rate for chronic myeloid leukemia (CML) patients has increased dramatically since imatinib was first approved for treatment in 2001.
Where do generic drugs come from? Medicines have a long lifecycle from research to brand name drug to generic form. Over time, innovation leads to increased competition on price and clinical effects.
Innovative treatments have transformed the way we attack many devastating diseases. Learn more about the key advances that have changed medicine over the last century.
Meet inspiring individuals who were diagnosed with a serious medical condition and learn how advanced medical technology helps them lead healthy lives once again.
New medicines, including combination treatments for HIV/AIDS, have transformed what was once a fatal diagnosis into a chronic disease for many patients.
Patient advocate David Mixner takes a personal look back at how the devastation caused by the HIV/AIDS epidemic spurred the evolution of therapeutic options for treatment.
Advances in treating debilitating diseases are often not the result of one single breakthrough, but rather an accumulation of knowledge and research over time.
Life is very different for rheumatoid arthritis patients today compared with just a few years ago. Find out how new medicines have helped.
New and forthcoming medicines can halt the progression of hepatitis C and, in many cases, provide a cure.
View stories from scientists and researchers working in drug discovery and development at America’s biopharmaceutical companies.
In the innovative research and development process, setbacks are in many ways as important as successes, helping to identify more promising areas to pursue.
Learn about the discovery and development process of life-saving or life-enhancing medicines, from initial research to delivery.
For decades, the U.S. biopharmaceutical industry has led the world in the discovery and development of new medicines. Will it stay that way?